“ELNs are quickly becoming the standard in global R&D labs, from pharmaceutical development to academic research,” said Accelrys President and Chief Executive Officer Max Carnecchia. “Accelrys, with our commitment to science and successful software deployments in various verticals, is uniquely positioned to partner with customers on an ELN implementation that will return immediate, measurable results. I look forward to further collaboration with Nippon Shinyaku and seeing how the progress they make will impact the next generation of pharmaceuticals.”About Symyx Notebook by Accelrys The multidisciplinary Symyx Notebook by Accelrys enables cross-disciplinary teams to collaborate more effectively in moving therapeutic substances and related information from research through development to early manufacturing using efficient, validated and compliant processes. With no custom coding required, the notebook offers out-of-the-box capabilities supporting analytical, process and formulation teams working in small and large molecule development. Integration of Symyx Notebook by Accelrys with existing laboratory information management systems (LIMS), scientific data management systems (SDMS), chromatography data systems (CDS) and other lab informatics solutions optimizes IP collection and transfer between scientific domains by ensuring consistent, accurate information storage and data processing. In pharmaceutical product development processes, the ELN helps build more efficient development processes. Furthermore, by reducing the time from pharmaceutical formulation to clinical trials, it accelerates the compilation of documents to be submitted under relevant legislation. About Accelrys Accelrys (NASDAQ:ACCL), a leading scientific enterprise R&D software and services company, supports industries and organizations that rely on science as a differentiator. Accelrys' Enterprise Research & Development Architecture, built on the industry-leading Pipeline Pilot™ platform, provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. Through its Enterprise R&D Architecture and market-leading electronic laboratory notebooks (ELNs), Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.
Headquartered in San Diego, Calif., Accelrys has more than 1,300 customers in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries and employs approximately 150 full-time Ph.D. scientists. For more information about Accelrys, visit www.accelrys.com.